Considering no changes in the levels of these two transporters were observed in our gefitinib-resistant NSCLC cells, we come to a conclusion that ABCB1 and ABCC1 are unlikely to play a role in the development of acquired resistance to gefitinib in NSCLC. Here, ABCC1 is linked to non-small cell lung carcinoma.